CN104045837B - A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application - Google Patents
A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application Download PDFInfo
- Publication number
- CN104045837B CN104045837B CN201410267395.1A CN201410267395A CN104045837B CN 104045837 B CN104045837 B CN 104045837B CN 201410267395 A CN201410267395 A CN 201410267395A CN 104045837 B CN104045837 B CN 104045837B
- Authority
- CN
- China
- Prior art keywords
- poly
- benzyl ester
- glutamic acid
- anhydrous
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001480 hydrophilic copolymer Polymers 0.000 title claims abstract description 46
- 238000010189 synthetic method Methods 0.000 title claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 132
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 132
- 238000006243 chemical reaction Methods 0.000 claims abstract description 96
- 239000012986 chain transfer agent Substances 0.000 claims abstract description 71
- 239000003814 drug Substances 0.000 claims abstract description 37
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims abstract description 36
- 229920001577 copolymer Polymers 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 25
- CNCOEDDPFOAUMB-UHFFFAOYSA-N N-Methylolacrylamide Chemical compound OCNC(=O)C=C CNCOEDDPFOAUMB-UHFFFAOYSA-N 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 229960004679 doxorubicin Drugs 0.000 claims abstract description 18
- 238000006698 hydrazinolysis reaction Methods 0.000 claims abstract description 6
- -1 poly(L-glutamic acid-γ-benzyl ester) Polymers 0.000 claims description 248
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 89
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 80
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 70
- 230000015572 biosynthetic process Effects 0.000 claims description 63
- 238000003786 synthesis reaction Methods 0.000 claims description 63
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 62
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 57
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 46
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 44
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 40
- BGGHCRNCRWQABU-JTQLQIEISA-N (2s)-2-amino-5-oxo-5-phenylmethoxypentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(=O)OCC1=CC=CC=C1 BGGHCRNCRWQABU-JTQLQIEISA-N 0.000 claims description 37
- 239000002244 precipitate Substances 0.000 claims description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- GDFCSMCGLZFNFY-UHFFFAOYSA-N Dimethylaminopropyl Methacrylamide Chemical compound CN(C)CCCNC(=O)C(C)=C GDFCSMCGLZFNFY-UHFFFAOYSA-N 0.000 claims description 32
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 32
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 claims description 30
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 29
- JHTGWMSMTTXVOC-UHFFFAOYSA-N 1-isocyanato-2-(2-isocyanatoethyldisulfanyl)ethane Chemical compound O=C=NCCSSCCN=C=O JHTGWMSMTTXVOC-UHFFFAOYSA-N 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 24
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 claims description 20
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 19
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 15
- 239000012975 dibutyltin dilaurate Substances 0.000 claims description 14
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 11
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 10
- 238000011068 loading method Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- HIZCIEIDIFGZSS-UHFFFAOYSA-L trithiocarbonate Chemical compound [S-]C([S-])=S HIZCIEIDIFGZSS-UHFFFAOYSA-L 0.000 claims description 8
- 239000012989 trithiocarbonate Substances 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 239000003999 initiator Substances 0.000 claims description 7
- 229920002521 macromolecule Polymers 0.000 claims description 7
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- RNTXYZIABJIFKQ-UHFFFAOYSA-N 4-cyano-4-dodecylsulfanylcarbothioylsulfanylpentanoic acid Chemical compound CCCCCCCCCCCCSC(=S)SC(C)(C#N)CCC(O)=O RNTXYZIABJIFKQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 3
- 150000008065 acid anhydrides Chemical class 0.000 claims description 3
- YOQLRQUGJROXRV-UHFFFAOYSA-N benzenecarbodithioic acid;4-cyanopentanoic acid Chemical compound N#CC(C)CCC(O)=O.SC(=S)C1=CC=CC=C1 YOQLRQUGJROXRV-UHFFFAOYSA-N 0.000 claims description 3
- YPCMISLZCVOUJB-UHFFFAOYSA-N 4-cyano-4-methyl-5-phenyl-5-sulfanylidenepentanoic acid Chemical compound OC(=O)CCC(C)(C#N)C(=S)C1=CC=CC=C1 YPCMISLZCVOUJB-UHFFFAOYSA-N 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000012456 homogeneous solution Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- NICLKHGIKDZZGV-UHFFFAOYSA-N 2-cyanopentanoic acid Chemical compound CCCC(C#N)C(O)=O NICLKHGIKDZZGV-UHFFFAOYSA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- 229930182816 L-glutamine Natural products 0.000 claims 1
- DDFGTVSLZJLQEV-UHFFFAOYSA-N [C](C1CCCCC1)C1CCCCC1 Chemical compound [C](C1CCCCC1)C1CCCCC1 DDFGTVSLZJLQEV-UHFFFAOYSA-N 0.000 claims 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 claims 1
- 229910000071 diazene Inorganic materials 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 20
- 229920000642 polymer Polymers 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000001308 synthesis method Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- 238000012712 reversible addition−fragmentation chain-transfer polymerization Methods 0.000 abstract description 3
- 238000007151 ring opening polymerisation reaction Methods 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 125000003277 amino group Chemical group 0.000 abstract description 2
- 150000003384 small molecules Chemical class 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 105
- 230000018044 dehydration Effects 0.000 description 29
- 238000006297 dehydration reaction Methods 0.000 description 29
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 238000004108 freeze drying Methods 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000012265 solid product Substances 0.000 description 9
- 210000004881 tumor cell Anatomy 0.000 description 9
- HMHYBQHINBJJGL-UHFFFAOYSA-N 4-[(4-carboxy-4-cyanobutan-2-yl)diazenyl]-2-cyanopentanoic acid Chemical compound N#CC(C(O)=O)CC(C)N=NC(C)CC(C#N)C(O)=O HMHYBQHINBJJGL-UHFFFAOYSA-N 0.000 description 8
- 108020004459 Small interfering RNA Proteins 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 229940044683 chemotherapy drug Drugs 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 125000002091 cationic group Chemical group 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- 231100000433 cytotoxic Toxicity 0.000 description 5
- 230000001472 cytotoxic effect Effects 0.000 description 5
- 229920001308 poly(aminoacid) Polymers 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229920000469 amphiphilic block copolymer Polymers 0.000 description 4
- 229920006317 cationic polymer Polymers 0.000 description 4
- 239000007857 degradation product Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002539 nanocarrier Substances 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000002648 combination therapy Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000036457 multidrug resistance Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 108010011110 polyarginine Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920000229 biodegradable polyester Polymers 0.000 description 1
- 239000004622 biodegradable polyester Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种三臂星形亲水性共聚物及其合成方法和应用,利用三元伯胺内核引发γ‑苄酯‑L‑谷氨酸‑N‑羧基环内酸酐开环聚合反应,利用碳二亚胺法将小分子RAFT聚合链转移剂键接于该星形聚合物的三个端氨基上,获得大分子RAFT链转移剂;再以N‑(3‑二甲胺丙基)甲基丙烯酰胺、N‑羟甲基丙烯酰胺为单体,实施RAFT聚合,最后利用共聚物中N‑羟甲基丙烯酰胺组分的羟基与异氰酸酯化端甲基聚乙二醇反应,实现经二硫键连接聚乙二醇,再经肼解处理后获得所需的三臂星形亲水性共聚物。该方法能够灵活控制各聚合物组分分子量大小和链长度、反应条件温和、原料易得,合成的聚合物能够提高药效,降低毒副作用,同时装载阿霉素和基因药物,实现协同抗肿瘤治疗效果。A three-armed star-shaped hydrophilic copolymer and its synthesis method and application, using the inner core of tertiary primary amine to initiate the ring-opening polymerization reaction of γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride in the ring, using carbon two The imine method bonds the small molecule RAFT polymeric chain transfer agent to the three terminal amino groups of the star polymer to obtain the macromolecular RAFT chain transfer agent; Amide and N-methylolacrylamide are used as monomers, and RAFT polymerization is carried out. Finally, the hydroxyl group of the N-methylolacrylamide component in the copolymer is used to react with the isocyanated methylated polyethylene glycol to achieve a disulfide bond. The desired three-arm star-shaped hydrophilic copolymer is obtained after linking polyethylene glycol and hydrazinolysis treatment. This method can flexibly control the molecular weight and chain length of each polymer component, the reaction conditions are mild, and the raw materials are easy to obtain. The synthesized polymer can improve drug efficacy and reduce toxic side effects. At the same time, doxorubicin and gene drugs are loaded to achieve synergistic anti-tumor treatment effect.
Description
技术领域 technical field
本发明属于生物医用材料领域,具体涉及一种三臂星形亲水性共聚物及其合成方法和应用。 The invention belongs to the field of biomedical materials, and in particular relates to a three-arm star-shaped hydrophilic copolymer and its synthesis method and application.
背景技术 Background technique
基于细胞毒药物的化疗是目前治疗恶性肿瘤的主要策略之一。然而,细胞毒药物通常细胞毒性大、水溶性差且无生物选择性,可同时杀死肿瘤细胞和正常细胞,毒副作用严重。由于化疗疗效和毒副作用均与药物剂量强烈正相关,因此很难通过提高药物浓度改善治疗效果。更为严重的是,细胞毒药物在化疗过程中,肿瘤细胞几乎都会出现多药耐药性。这些成为制约化疗成功的主要障碍。近年许多研究表明,利用生物相容性和生物可降解性高分子材料等生物材料负载化疗药物,可有效增加肿瘤组织局部药物浓度,提高药物生物利用度,实现增强治疗效果、降低对正常细胞毒副作用的目的。目前,药物载体材料研究最多的是生物相容性好、可生物降解的聚酯材料,如聚丙交酯、聚乙丙交酯、聚己内酯等。这些疏水性聚酯材料可有效装载疏水性的细胞毒药物,但它们主要通过水解降解方式释放药物,速度较慢,影响药效发挥,可见它们并非是理想的药物载体材料。因此,合成新型药物载体材料的和开发新型药物释放机制一直都是研究热点。近几年,聚氨基酸如聚谷氨酸和聚赖氨酸因具有良好的生物相容性和生物可降解性,在药物递送领域引起兴趣。聚氨基酸是一类通过肽键连接的、由氨基酸及其衍生物构成的均聚或共聚高分子材料。不同氨基酸呈现不同的侧基、荷电性质和亲疏水性,可灵活调节聚氨基酸理化性质,如降解性能、生物相容性、自组装行为等。此外,聚氨基酸的降解产物为近中性的氨基酸,可避免传统聚酯材料酸性降解产物带来的炎性反应等副作用。可见,聚氨基酸及其衍生物在药物递送方面具有广阔的开发前景。如申请号为201110132965.2的中国专利公开了利用端 氨基聚乙二醇引发L-色氨酸聚合制备两亲性嵌段共聚物的制备方法,所得共聚物可形成胶束,用于紫杉醇等药物的装载。再如申请号为201110200449.9的中国专利公开了一种还原敏感性的嘌呤-聚天冬酰亚胺前药,其中含有的二硫键可在肿瘤细胞内谷胱甘肽还原作用下发生降解,释放药物,具有降低毒副作用和提高疗效的作用。 Chemotherapy based on cytotoxic drugs is one of the main strategies for the treatment of malignant tumors. However, cytotoxic drugs usually have high cytotoxicity, poor water solubility and no bioselectivity, and can kill tumor cells and normal cells at the same time, with serious side effects. Since the curative effect and side effects of chemotherapy are strongly positively correlated with the drug dose, it is difficult to improve the therapeutic effect by increasing the drug concentration. What's more serious is that almost all tumor cells will develop multidrug resistance during chemotherapy with cytotoxic drugs. These have become the main obstacles restricting the success of chemotherapy. Many studies in recent years have shown that the use of biological materials such as biocompatible and biodegradable polymer materials to load chemotherapy drugs can effectively increase the local concentration of drugs in tumor tissues, improve the bioavailability of drugs, achieve enhanced therapeutic effects, and reduce toxicity to normal cells. purpose of side effects. At present, the most researched drug carrier materials are biocompatible and biodegradable polyester materials, such as polylactide, polyglycolide, polycaprolactone, etc. These hydrophobic polyester materials can effectively load hydrophobic cytotoxic drugs, but they mainly release drugs through hydrolytic degradation, which is slow and affects drug efficacy. It can be seen that they are not ideal drug carrier materials. Therefore, the synthesis of new drug carrier materials and the development of new drug release mechanisms have always been research hotspots. In recent years, polyamino acids such as polyglutamic acid and polylysine have attracted interest in the field of drug delivery due to their good biocompatibility and biodegradability. Polyamino acids are a class of homopolymeric or copolymeric polymer materials composed of amino acids and their derivatives linked by peptide bonds. Different amino acids exhibit different side groups, charging properties, and hydrophilic and hydrophobic properties, which can flexibly adjust the physical and chemical properties of polyamino acids, such as degradation performance, biocompatibility, and self-assembly behavior. In addition, the degradation products of polyamino acids are near-neutral amino acids, which can avoid side effects such as inflammatory reactions caused by acidic degradation products of traditional polyester materials. It can be seen that polyamino acids and their derivatives have broad development prospects in drug delivery. For example, the Chinese patent application number 201110132965.2 discloses a method for preparing an amphiphilic block copolymer by using amino-terminated polyethylene glycol to initiate L-tryptophan polymerization. load. Another example is that the Chinese patent application number 201110200449.9 discloses a reduction-sensitive purine-polyaspartimide prodrug, which contains a disulfide bond that can be degraded under the reduction of glutathione in tumor cells, releasing The medicine has the functions of reducing toxic and side effects and improving curative effect.
不管是聚酯或是聚氨基酸用作化疗药物载体时,都必须将其与亲水性聚乙二醇形成两亲性嵌段共聚物,以便能在水中自组装成具有疏水内核和亲水外壳的纳米胶束。其中,疏水性内核用于包裹疏水性化疗药物,亲水性外壳可使纳米载体稳定、防止胶束聚并,免受免疫系统调理作用,实现体内长循环。相对于传统的小分子脂质体胶束而言,两亲性嵌段共聚物具有更低的临界胶束浓度,在血液中的稳定性更好,并可经肿瘤组织特殊的‘增强的渗透和滞留效应’实现被动靶向,将药物有效富集于肿瘤组织内部,促进肿瘤细胞对载体-药物的摄取。然而,单纯依靠两亲性嵌段共聚物自组装形成的纳米胶束,当注射进入体内后由于稀释效应,仍存在胶束解离提前释放药物的风险。 Whether polyester or polyamino acid is used as a chemotherapy drug carrier, it must be combined with hydrophilic polyethylene glycol to form an amphiphilic block copolymer, so that it can self-assemble in water to have a hydrophobic core and a hydrophilic shell of nanomicelles. Among them, the hydrophobic inner core is used to wrap hydrophobic chemotherapy drugs, and the hydrophilic outer shell can stabilize the nanocarriers, prevent micelles from aggregating, avoid the conditioning effect of the immune system, and realize long-term circulation in the body. Compared with traditional small-molecule liposome micelles, amphiphilic block copolymers have lower critical micelle concentration, better stability in blood, and special 'enhanced penetration' through tumor tissue and retention effect' to achieve passive targeting, effectively enrich the drug inside the tumor tissue, and promote the uptake of the carrier-drug by tumor cells. However, nanomicelles formed solely by the self-assembly of amphiphilic block copolymers still have the risk of micelles dissociation and early drug release due to the dilution effect after injection into the body.
近年,基因治疗被视为治疗恶性肿瘤的很有前景的新策略,它通过将外源性的治疗性基因导入肿瘤细胞中,以纠正缺陷基因或抑制/促进某种基因/蛋白质表达,从而达到治疗疾病的目的。同时,基因治疗也是克服化疗中肿瘤细胞多药耐药性的有效途径。为克服基因治疗中病毒类载体存在的安全性、装载能力有限、潜在免疫反应及致癌作用等问题,对于非病毒类载体的研究已成为新的热点。非病毒类载体具有安全性高、免疫原性低、携带量大、易批量生产等优点,主要包括阳离子脂质体和阳离子聚合物两类。其中,阳离子聚合物是研究主体,可经静电作用与基因物质形成稳定的复合物,有效压缩基因物质,协助基因穿过胞膜。聚乙烯亚胺是最经典的阳离子聚合物载体,具有原料易得、压缩比高、缓冲能力强和转染效率高等优点,研究最为集中。然而,聚乙烯亚胺由于不可降解且细胞毒性大,制约着其应用范围。 In recent years, gene therapy has been regarded as a promising new strategy for the treatment of malignant tumors. It introduces exogenous therapeutic genes into tumor cells to correct defective genes or inhibit/promote the expression of certain genes/proteins, thereby achieving purpose of treating disease. At the same time, gene therapy is also an effective way to overcome the multidrug resistance of tumor cells in chemotherapy. In order to overcome the safety, limited loading capacity, potential immune response and carcinogenesis of viral vectors in gene therapy, research on non-viral vectors has become a new focus. Non-viral vectors have the advantages of high safety, low immunogenicity, large carrying capacity, and easy mass production, and mainly include cationic liposomes and cationic polymers. Among them, the cationic polymer is the subject of research, which can form a stable complex with the genetic material through electrostatic interaction, effectively compress the genetic material, and assist the gene to pass through the cell membrane. Polyethyleneimine is the most classic cationic polymer carrier, which has the advantages of easy availability of raw materials, high compression ratio, strong buffer capacity and high transfection efficiency, and the research is the most concentrated. However, polyethyleneimine is non-degradable and highly cytotoxic, which restricts its application range.
目前,利用不同作用机制和不同类型药物联合治疗恶性肿瘤已成为发展 趋势,尤其是基于纳米载体的联合治疗更被寄予厚望。然而,基于纳米载体的联合治疗最大的瓶颈问题是合成出理想的可同时装载不同药物的载体材料。申请号为201210114241.X的中国专利公开了由聚乙二醇、聚乳酸和聚精氨酸构成的三嵌段共聚物,其中聚酯段和聚精氨酸段分别用于装载疏水性药物和基因物质,具有良好的生物安全性和药物递送能力。但该嵌段共聚物的段间通过酯键和氨酯键连接,没有刺激响应性的解离机制,药物释放速度较慢,难以充分发挥药物疗效。 At present, it has become a development trend to use different mechanisms of action and different types of drugs to treat malignant tumors in combination, especially the combination therapy based on nanocarriers has high hopes. However, the biggest bottleneck of nanocarrier-based combination therapy is the synthesis of ideal carrier materials that can simultaneously load different drugs. The Chinese patent application number 201210114241.X discloses a triblock copolymer composed of polyethylene glycol, polylactic acid and polyarginine, in which the polyester segment and the polyarginine segment are used to load hydrophobic drugs and Genetic material with good biosafety and drug delivery capabilities. However, the segments of the block copolymer are connected by ester bonds and urethane bonds, there is no stimuli-responsive dissociation mechanism, and the drug release rate is slow, making it difficult to give full play to the curative effect of the drug.
发明内容 Contents of the invention
本发明的目的在于提供一种三臂星形水溶性共聚物及其合成方法和应用,该方法能够灵活控制各聚合物组分分子量大小和链长度、反应条件温和、原料易得,合成的聚合物能够提高药效,降低毒副作用,同时装载阿霉素和基因药物,实现协同抗肿瘤治疗效果。 The purpose of the present invention is to provide a three-arm star-shaped water-soluble copolymer and its synthesis method and application. The method can flexibly control the molecular weight and chain length of each polymer component, the reaction conditions are mild, and the raw materials are easy to obtain. Drugs can improve drug efficacy, reduce toxic and side effects, and simultaneously load doxorubicin and gene drugs to achieve synergistic anti-tumor therapeutic effects.
为达到上述目的,本发明三臂星形亲水性共聚物的合成方法,其特征在于,包括如下步骤: In order to achieve the above object, the synthetic method of three-arm star-shaped hydrophilic copolymer of the present invention is characterized in that, comprises the steps:
1)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 1) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将除水后的三臂聚(L-谷氨酸-γ-苄酯)溶于无水有机溶剂中,然后在氮气气氛下于0℃~4℃加入带一个羧基的RAFT链转移剂、4-二甲氨基吡啶和二环己基碳二亚胺,再在室温反应24小时~72小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂;其中,除水后的聚(L-谷氨酸-γ-苄酯)、带一个羧基的RAFT链转移剂、4-二甲氨基吡啶以及二环己基碳二亚胺的摩尔比为1:(6~20):3:(6~60); Dissolve the three-armed poly(L-glutamic acid-γ-benzyl ester) after water removal in an anhydrous organic solvent, and then add a RAFT chain transfer agent with a carboxyl group at 0°C to 4°C under a nitrogen atmosphere, 4 -Dimethylaminopyridine and dicyclohexylcarbodiimide, react at room temperature for 24 hours to 72 hours, then precipitate with cold ether, collect the precipitate and dry it in vacuum to obtain three-arm poly(L-glutamic acid-γ-benzyl ester ) Macromolecular RAFT chain transfer agent; wherein, poly(L-glutamic acid-γ-benzyl ester) after water removal, RAFT chain transfer agent with a carboxyl group, 4-dimethylaminopyridine and dicyclohexylcarbodiethylene The molar ratio of amine is 1:(6~20):3:(6~60);
2)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的合成: 2) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide):
将三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂、N-(3-二甲胺丙基)甲基丙烯酰胺、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后在无氧环境下加入引发剂,于60℃~65℃反应36小时~72小时,反应结束后浓缩得到的反应 体系,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺);其中,三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂、N-(3-二甲胺丙基)甲基丙烯酰胺以及N-羟甲基丙烯酰胺的摩尔比为1:(72~290):(3.6~14.4); Dissolve three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecule RAFT chain transfer agent, N-(3-dimethylaminopropyl)methacrylamide, N-methylolacrylamide in anhydrous In dioxane, then add the initiator in an oxygen-free environment, react at 60 ° C ~ 65 ° C for 36 hours ~ 72 hours, after the reaction is completed, concentrate the obtained reaction system, then dissolve it in dichloromethane and precipitate it in cold ether , the precipitate was collected and dried in vacuo to obtain three-armed star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide); among them, the three-armed poly The molar ratio of (L-glutamic acid-γ-benzyl ester) macromolecule RAFT chain transfer agent, N-(3-dimethylaminopropyl)methacrylamide and N-methylolacrylamide is 1:(72 ~290): (3.6~14.4);
3)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 3) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
将除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)溶解于无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃~65℃反应36小时~72小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析,最后冻干,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,异氰酸酯化的端甲氧基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为(9~36):1; Dissolve the three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) after water removal in anhydrous chloroform, and then add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol, react at 60°C to 65°C for 36 hours to 72 hours, concentrate the obtained reaction system after the reaction, and precipitate with ether, then Dialyzed in distilled water, and finally freeze-dried to obtain three-armed star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene bismuth Alcohol copolymer; wherein, isocyanated end-methoxy polyethylene glycol and three-armed star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl base) methacrylamide) molar ratio is (9 ~ 36): 1;
4)三臂星形亲水性共聚物的合成:将三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物肼解脱除苄基,得到三臂星形亲水性共聚物。 4) Synthesis of three-armed star-shaped hydrophilic copolymer: the three-armed star-shaped poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide )-Polyethylene glycol copolymer hydrazinolysis removes the benzyl group to obtain a three-armed star-shaped hydrophilic copolymer.
所述的步骤1)中的聚(L-谷氨酸-γ-苄酯)是采用以下方法制得的:将无水的三(2-氨基乙基)胺溶于无水有机溶剂中,在氮气气氛下加入γ-苄酯-L-谷氨酸-N-羧基环内酸酐,搅拌形成均匀溶液,然后于25℃~40℃反应48小时~72小时,反应结束后将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到聚(L-谷氨酸-γ-苄酯);其中,无水的三(2-氨基乙基)胺和γ-苄酯-L-谷氨酸-N-羧基环内酸酐的摩尔比为(1:30)~(1:120),且步骤1)和步骤4)中的无水有机溶剂为无水二甲基甲酰胺、无水氯仿或无水四氢呋喃。 The poly(L-glutamic acid-γ-benzyl ester) in the described step 1) is prepared by the following method: anhydrous tris(2-aminoethyl)amine is dissolved in anhydrous organic solvent, Add γ-benzyl ester-L-glutamic acid-N-carboxyl internal anhydride under nitrogen atmosphere, stir to form a homogeneous solution, and then react at 25°C to 40°C for 48 hours to 72 hours. After the reaction, the obtained reaction solution Precipitate with cold ether and wash with ethanol, and obtain poly(L-glutamic acid-γ-benzyl ester) after vacuum drying; wherein, anhydrous tris(2-aminoethyl)amine and γ-benzyl ester-L-glutamine The molar ratio of the acid anhydride in the acid-N-carboxyl ring is (1:30)~(1:120), and the anhydrous organic solvent in step 1) and step 4) is anhydrous dimethyl formamide, anhydrous chloroform or anhydrous tetrahydrofuran.
所述的无水的三(2-氨基乙基)胺是经氢化钙回流,氮气气氛下减压蒸馏得到的。 The anhydrous tris(2-aminoethyl)amine is obtained by refluxing calcium hydride and distilling under reduced pressure under a nitrogen atmosphere.
所述的γ-苄酯-L-谷氨酸-N-羧基环内酸酐由以下步骤合成:将L-谷氨酸-γ- 苄酯加入无水四氢呋喃中,接着在氮气氛下加入三光气,随后于50℃反应至形成澄清溶液后浓缩,最后向浓缩后得到的反应体系中加入无水正己烷使沉淀,将得到的沉淀用无水正己烷重结晶,得到γ-苄酯-L-谷氨酸-N-羧基环内酸酐;其中,L-谷氨酸-γ-苄酯与三光气的摩尔比为1:(0.35~0.4)。 The γ-benzyl ester-L-glutamic acid-N-carboxyl ring anhydride is synthesized by the following steps: L-glutamic acid-γ-benzyl ester is added in anhydrous tetrahydrofuran, and then triphosgene is added under a nitrogen atmosphere , followed by reacting at 50°C until a clear solution was formed and concentrated, and finally adding anhydrous n-hexane to the reaction system obtained after concentration to precipitate, and recrystallizing the obtained precipitate with anhydrous n-hexane to obtain γ-benzyl ester-L- Glutamic acid-N-carboxyl ring anhydride; wherein, the molar ratio of L-glutamic acid-γ-benzyl ester to triphosgene is 1:(0.35~0.4).
所述的步骤4)肼解脱除苄基的方法为:将三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水有机溶剂中,滴加无水肼后于30℃~40℃反应18小时~48小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为(3~20):1。 The method of step 4) hydrazinolysis to remove benzyl group is: three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl) methacrylic acid Amide)-polyethylene glycol copolymer is dissolved in anhydrous organic solvent, after adding anhydrous hydrazine dropwise, react at 30 ℃ ~ 40 ℃ for 18 hours ~ 48 hours, after the reaction is completed, the reaction system obtained is 0.25% in mass concentration Dialyzed in aqueous ammonia, and finally freeze-dried to obtain a three-armed star-shaped hydrophilic copolymer; wherein, anhydrous hydrazine and three-armed star-shaped poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3 - dimethylaminopropyl) methacrylamide) - the molar ratio of the benzyl protecting group in the polyethylene glycol copolymer is (3-20):1.
所述的步骤1)中带一个羧基的RAFT链转移剂为S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯、4-氰基-4-[(十二烷基硫烷基硫羰基)硫烷基]戊酸、4-氰基-4-(硫代苯甲酰)戊酸或4-氰基戊酸二硫代苯甲酸。 The RAFT chain transfer agent with a carboxyl group in the step 1) is S-1-dodecyl-S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate, 4 -Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid, 4-cyano-4-(thiobenzoyl)pentanoic acid, or 4-cyanopentanoic acid dithio Benzoic acid.
所述的步骤2)中的引发剂为偶氮二异丁腈或4,4'-偶氮双(氰基戊酸),且三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂与引发剂的摩尔比为1:(0.36~1.44)。 The initiator in the step 2) is azobisisobutyronitrile or 4,4'-azobis(cyanovaleric acid), and the three-arm poly(L-glutamic acid-γ-benzyl ester) is large The molar ratio of molecular RAFT chain transfer agent to initiator is 1: (0.36-1.44).
所述的步骤3)中2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇是采用如下方法合成的:将分子量为800~4000Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,收集沉淀并真空干燥,即得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:(0.02~0.08):(3~8)。 The methyl-terminated polyethylene glycol modified with 2,2'-dithiodiethylisocyanate in the step 3) is synthesized by the following method: the methoxy-terminated polyethylene glycol with a molecular weight of 800-4000Da Alcohol, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate were dissolved in anhydrous toluene, and reacted for 48 hours at 85°C under a nitrogen atmosphere, and anhydrous n-hexane was added to the obtained reaction system to precipitate , collect the precipitate and dry it in vacuum to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, dibutyltin dilaurate and 2, The molar ratio of 2'-dithiodiethylisocyanate is 1:(0.02~0.08):(3~8).
一种采用所述的方法合成的三臂星形亲水性共聚物,其化学名称为三臂星形聚(L-谷氨酸-γ-酰肼)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物,化学结构为: A three-arm star-shaped hydrophilic copolymer that adopts the synthesis of the method, and its chemical name is three-arm star-shaped poly(L-glutamic acid-γ-hydrazide)-poly(N-(3-dimethyl Aminopropyl) methacrylamide)-polyethylene glycol copolymer, the chemical structure is:
所述的三臂星形亲水性共聚物作为装载阿霉素和基因药物的载体的应用。 The application of the three-arm star-shaped hydrophilic copolymer as a carrier loaded with doxorubicin and gene medicine.
每100毫升无水有机溶剂中溶解1g~6g的聚(L-谷氨酸-γ-苄酯); Dissolve 1g to 6g of poly(L-glutamic acid-γ-benzyl ester) in every 100 milliliters of anhydrous organic solvent;
步骤2)中,每100毫升无水二氧六环中加入2g~10g的三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂; In step 2), 2 g to 10 g of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecule RAFT chain transfer agent is added to every 100 milliliters of anhydrous dioxane;
步骤3)中每100毫升无水氯仿中溶解2g~5g除水后的tPBLG-b-PDMAPMA; Dissolve 2g to 5g of tPBLG-b-PDMAPMA after dehydration in every 100ml of anhydrous chloroform in step 3);
每100毫升无水四氢呋喃中溶解5g~15g的L-谷氨酸-γ-苄酯。 Dissolve 5g-15g of L-glutamic acid-γ-benzyl ester per 100ml of anhydrous tetrahydrofuran.
每100毫升无水有机溶剂中溶解5g~15g的γ-苄酯-L-谷氨酸-N-羧基环内酸酐; Dissolve 5g to 15g of gamma-benzyl ester-L-glutamic acid-N-carboxyl internal anhydride in every 100 milliliters of anhydrous organic solvent;
每100毫升无水甲苯中溶解5g~30g的端甲基聚乙二醇。 Dissolve 5g-30g of methyl-terminated polyethylene glycol per 100ml of anhydrous toluene.
所述的三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂与引发剂的摩尔比为1:(0.36~1.44); The molar ratio of the three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecule RAFT chain transfer agent to the initiator is 1: (0.36-1.44);
所述的基因药物为Pgp siRNA、bcl-2siRNA或EGF siRNA,其装载方法是将基因药物和装载阿霉素后的三臂星形水溶性共聚物混合,经涡旋振荡器混合形成复合物,实现基因药物的装载。 The gene drug is Pgp siRNA, bcl-2 siRNA or EGF siRNA, and the loading method is to mix the gene drug and the three-arm star-shaped water-soluble copolymer loaded with doxorubicin, and form a complex by mixing with a vortex shaker, Realize the loading of gene medicine.
所述的步骤5)中每100毫升无水有机溶剂中溶解5g~30g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve 5g~30g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl) per 100 ml of anhydrous organic solvent in the step 5) methacrylamide)-polyethylene glycol copolymer.
与现有技术相比,本发明的有益效果在于: Compared with prior art, the beneficial effect of the present invention is:
(一)本发明合成的三臂星形水溶性共聚物由实现体内隐形作用的聚乙 二醇、通过腙键键接化疗药阿霉素的聚(L-谷氨酸-γ-酰肼)段以及经静电作用负载基因物质的人工合成阳离子聚(N-(3-二甲胺丙基)甲基丙烯酰胺)组成,因此,本发明合成的三臂星形水溶性共聚物能够同时装载化疗药阿霉素和基因物质,实现协同抗肿瘤治疗效果。 (1) The three-arm star-shaped water-soluble copolymer synthesized by the present invention is composed of poly(L-glutamic acid-γ-hydrazide) of poly(L-glutamic acid-γ-hydrazide) which realizes the stealth effect in vivo, and is bonded with the chemotherapeutic drug doxorubicin by a hydrazone bond. Segment and artificially synthesized cationic poly(N-(3-dimethylaminopropyl)methacrylamide) composed of electrostatically charged gene substances, therefore, the three-arm star-shaped water-soluble copolymer synthesized by the present invention can simultaneously load chemotherapy Drug doxorubicin and genetic material to achieve synergistic anti-tumor therapeutic effect.
其中,连接聚乙二醇的功能性桥键含二硫键,这样装载了阿霉素和基因药物的载体一端进入肿瘤细胞内就能够响应肿瘤细胞内还原性环境而断裂,脱去聚乙二醇后暴露出载基因药物的阳离子层,暴露的阳离子层能够促进药物-载体从内涵体逃逸至细胞质,释放所载药物,同时避免溶酶体的酶解作用,从而提高药效,降低毒副作用。本发明的聚(L-谷氨酸-γ-酰肼)段由开环聚合法制备,其最终降解产物为谷氨酸,可被人体吸收利用,不会导致聚酯材料酸性降解产物的不利影响。而不可降解的阳离子聚(N-(3-二甲胺丙基)甲基丙烯酰胺)段是由RAFT聚合方法合成的,分子量分布窄且分子量大小可控,通过有效控制其分子量,既能够确保基因物质的装载效果,又能够保证通过排泄系统排出体外,避免其在体内的蓄积。 Among them, the functional bridge connecting polyethylene glycol contains a disulfide bond, so that when one end of the carrier loaded with doxorubicin and gene drug enters the tumor cell, it can be broken in response to the reducing environment in the tumor cell, and the polyethylene glycol can be removed. The cationic layer of the gene-loaded drug is exposed after alcohol, and the exposed cationic layer can promote the escape of the drug-carrier from the endosome to the cytoplasm, release the loaded drug, and avoid the enzymatic hydrolysis of the lysosome, thereby improving drug efficacy and reducing side effects . The poly(L-glutamic acid-γ-hydrazide) segment of the present invention is prepared by a ring-opening polymerization method, and its final degradation product is glutamic acid, which can be absorbed and utilized by the human body without causing disadvantages of acidic degradation products of polyester materials. influences. The non-degradable cationic poly(N-(3-dimethylaminopropyl)methacrylamide) segment is synthesized by RAFT polymerization method, the molecular weight distribution is narrow and the molecular weight is controllable, by effectively controlling its molecular weight, it is possible to ensure The loading effect of genetic material can also ensure that it is excreted through the excretory system to avoid its accumulation in the body.
(二)本发明的合成方法可灵活控制各聚合物组分分子量大小和链长度、反应条件温和、原料易得,合成的三臂星形水溶性共聚物具有水溶性,装载化疗药阿霉素后在水溶液中能够自组装形成单分子纳米胶束,单分子纳米胶束经肿瘤组织‘增强的渗透和滞留效应’被动靶向而富集于肿瘤组织内,促进肿瘤细胞摄取载体-药物,提高药物生物利用度,从而提高疗效和降低毒副作用。 (2) The synthesis method of the present invention can flexibly control the molecular weight and chain length of each polymer component, the reaction conditions are mild, and the raw materials are easy to get. The three-arm star-shaped water-soluble copolymer synthesized has water solubility and is loaded with the chemotherapeutic drug doxorubicin Afterwards, it can self-assemble in aqueous solution to form single-molecule nanomicelles, which are passively targeted by tumor tissue through the "enhanced penetration and retention effect" and enriched in tumor tissues, promoting the uptake of carrier-drugs by tumor cells, improving Drug bioavailability, thereby improving efficacy and reducing side effects.
同时,自组装成的单分子纳米胶束具有星形结构,形成的纳米胶束将具有比线性两亲性共聚物更高的稳定性,更低的临界胶束浓度,更长的体内循环时间,因此,三臂星形水溶性共聚物载药后在体内稳定性更高,具有被动靶向作用,可提高药物疗效和降低毒副作用。 At the same time, self-assembled unimolecular nanomicelles have a star-shaped structure, and the formed nanomicelles will have higher stability, lower critical micelle concentration, and longer circulation time in vivo than linear amphiphilic copolymers. Therefore, the three-armed star-shaped water-soluble copolymer has higher stability in vivo after drug loading, has passive targeting effect, can improve drug efficacy and reduce toxic and side effects.
(三)三臂星形水溶性共聚物上的聚乙二醇段的数量能够通过阳离子段聚合物中N-羟甲基丙烯酰胺数量灵活调节,单一臂上可连接一个聚乙二醇段而呈现三嵌段共聚物分子结构,也可连接数个聚乙二醇段而呈现嵌段和梳形 结构结合的分子结构,使纳米胶束亲水性外壳理化性质调节更为灵活。 (3) The number of polyethylene glycol segments on the three-arm star-shaped water-soluble copolymer can be flexibly adjusted by the number of N-methylolacrylamide in the cationic segment polymer, and a polyethylene glycol segment can be connected to a single arm. It presents a tri-block copolymer molecular structure, and can also link several polyethylene glycol segments to present a molecular structure combining a block and a comb structure, which makes the adjustment of the physical and chemical properties of the hydrophilic shell of the nano-micelle more flexible.
附图说明 Description of drawings
图1是本发明的三臂星形亲水性共聚物的合成路线示意图; Fig. 1 is the synthetic route synoptic diagram of three-arm star-shaped hydrophilic copolymer of the present invention;
图2是实施例1合成的三臂星形聚(L-谷氨酸-γ-酰肼)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇水溶性共聚物的1H-NMR谱图。 Fig. 2 is the three-arm star poly(L-glutamic acid-γ-hydrazide)-poly(N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol water-soluble compound synthesized in Example 1. The 1 H-NMR spectrum of the copolymer.
图3是实施例1合成的载体装载阿霉素后自组装纳米粒的粒径分布图。 Fig. 3 is a particle size distribution diagram of self-assembled nanoparticles loaded with doxorubicin on the carrier synthesized in Example 1.
图4是实施例1合成的三臂星形亲水性共聚物共载阿霉素和FAM标记siRNA的纳米粒进入乳腺癌细胞MCF-7内的激光共聚焦荧光照片;其中,a为DAPI染色的细胞核的荧光照片,b为细胞核处的阿霉素荧光照片,c为FAM标记的siRNA进入细胞后的荧光照片,d为a-c的组合图。 Fig. 4 is the laser confocal fluorescence photo of the three-arm star-shaped hydrophilic copolymer synthesized in Example 1 co-loading doxorubicin and FAM-labeled siRNA nanoparticles into the breast cancer cell MCF-7; wherein, a is DAPI staining The fluorescent photo of the cell nucleus, b is the fluorescent photo of doxorubicin at the nucleus, c is the fluorescent photo of FAM-labeled siRNA after entering the cell, and d is the combination of a-c.
具体实施方式 detailed description
参见图1,本发明以三(2-氨基乙基)胺为内核引发γ-苄酯-L-谷氨酸-N-羧基环内酸酐开环聚合,形成三臂聚(L-谷氨酸-γ-苄酯)分子;接着,利用碳二亚胺法在其端氨基上连接带一个羧基的RAFT链转移剂,实施RAFT聚合合成阳离子聚合物段;最后,键接异氰酸酯化的端甲基聚乙二醇,并经肼解处理后获得所需的三臂星形亲水性共聚物,可用于化疗药物阿霉素和基因物质的同时装载和递送。 Referring to Fig. 1, the present invention uses three (2-aminoethyl) amines as the inner core to initiate the ring-opening polymerization of γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride to form three-armed poly(L-glutamic acid -γ-benzyl ester) molecule; then, use the carbodiimide method to connect a RAFT chain transfer agent with a carboxyl group on its terminal amino group, and implement RAFT polymerization to synthesize a cationic polymer segment; finally, bond the isocyanated terminal methyl group Polyethylene glycol, and after hydrazinolysis treatment to obtain the desired three-armed star-shaped hydrophilic copolymer, can be used for the simultaneous loading and delivery of the chemotherapeutic drug doxorubicin and genetic material.
下面通过实施例对本发明作进一步描述,但本发明并不限于此。 The present invention will be further described below by way of examples, but the present invention is not limited thereto.
实施例1: Example 1:
1)γ-苄酯-L-谷氨酸-N-羧基环内酸酐(BLG-NCA)合成: 1) Synthesis of γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride (BLG-NCA):
将L-谷氨酸-γ-苄酯加入无水四氢呋喃中,接着在氮气氛下加入三光气,随后于50℃反应至形成澄清溶液后减压浓缩以除去大部分溶剂以浓缩溶剂,最后向浓缩后得到的反应体系中加入无水正己烷使沉淀,将得到的沉淀用无水正己烷重结晶,得到γ-苄酯-L-谷氨酸-N-羧基环内酸酐(BLG-NCA);其中,L-谷氨酸-γ-苄酯与三光气的摩尔比为1:0.35,每100毫升无水四氢呋喃中溶解10g的L-谷氨酸-γ-苄酯; Add L-glutamic acid-γ-benzyl ester into anhydrous tetrahydrofuran, then add triphosgene under nitrogen atmosphere, then react at 50°C until a clear solution is formed, then concentrate under reduced pressure to remove most of the solvent to concentrate the solvent, and finally to Add anhydrous n-hexane to the reaction system obtained after concentration to precipitate, and recrystallize the obtained precipitate with anhydrous n-hexane to obtain γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride (BLG-NCA) ; Wherein, the molar ratio of L-glutamic acid-γ-benzyl ester to triphosgene is 1:0.35, and 10g of L-glutamic acid-γ-benzyl ester is dissolved in every 100 milliliters of anhydrous tetrahydrofuran;
2)三臂聚(L-谷氨酸-γ-苄酯)(tPBLG)的合成: 2) Synthesis of three-arm poly(L-glutamate-γ-benzyl ester) (tPBLG):
将三(2-氨基乙基)胺经氢化钙回流12小时、氮气气氛下减压蒸馏得到无水三(2-氨基乙基)胺,然后将无水三(2-氨基乙基)胺溶于无水二甲基甲酰胺中,在氮气气氛下加入BLG-NCA,搅拌形成均匀溶液,然后于25℃反应72小时;反应结束后将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到白色粉末状的三臂聚(L-谷氨酸-γ-苄酯)(tPBLG);其中,无水的三(2-氨基乙基)胺和BLG-NCA的摩尔比为1:30,每100毫升无水二甲基甲酰胺中溶解15g的BLG-NCA; Reflux tris(2-aminoethyl)amine through calcium hydride for 12 hours, and distill under reduced pressure under nitrogen atmosphere to obtain anhydrous tris(2-aminoethyl)amine, then dissolve anhydrous tris(2-aminoethyl)amine In anhydrous dimethylformamide, add BLG-NCA under a nitrogen atmosphere, stir to form a uniform solution, and then react at 25°C for 72 hours; after the reaction, the obtained reaction solution is precipitated with cold ether and washed with ethanol, and dried in vacuo After that, white powdery three-arm poly(L-glutamic acid-γ-benzyl ester) (tPBLG) was obtained; wherein, the molar ratio of anhydrous tris(2-aminoethyl)amine and BLG-NCA was 1:30 , dissolve 15g of BLG-NCA per 100ml of anhydrous dimethylformamide;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的三臂聚(L-谷氨酸-γ-苄酯)溶于无水氯仿中,然后在氮气气氛下于0℃加入S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯(DDACT)、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),再在室温反应48小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、DDACT、DMAP以及DCC的摩尔比为1:6:3:12,每100毫升无水氯仿中溶解3g除水后的tPBLG,共沸除水时回流温度为120℃,除水时间2小时; tPBLG was dewatered by azeotropic toluene under nitrogen to obtain tPBLG after dehydration, and the three-armed poly(L-glutamic acid-γ-benzyl ester) after dehydration was dissolved in anhydrous chloroform, and then in a nitrogen atmosphere Add S-1-dodecyl-S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate (DDACT) and 4-dimethylaminopyridine (DMAP) at 0°C and dicyclohexylcarbodiimide (DCC), then precipitated with cold ether after reacting at room temperature for 48 hours, collected the precipitate and vacuum-dried to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) Molecular RAFT chain transfer agent, that is, tPBLG-CTA; wherein, the molar ratio of tPBLG, DDACT, DMAP and DCC after water removal is 1:6:3:12, and 3g of tPBLG after water removal is dissolved in 100 ml of anhydrous chloroform , the reflux temperature during azeotropic water removal is 120°C, and the water removal time is 2 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入偶氮二异丁腈,于60℃反应48小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和偶氮二异丁腈的摩尔比为1:72:3.6:0.36,每100毫升无水二氧六环中溶解20g的tPBLG-CTA; Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add azo Diisobutyronitrile was reacted at 60°C for 48 hours. After the reaction, the resulting reaction system was concentrated under reduced pressure to remove the solvent, dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and dried in vacuo to obtain an arm star polymer (L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide), that is, tPBLG-b-PDMAPMA; among them, tPBLG-CTA, DMAPMA, N-hydroxy The molar ratio of methacrylamide and azobisisobutyronitrile is 1:72:3.6:0.36, and 20g of tPBLG-CTA is dissolved in every 100ml of anhydrous dioxane;
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成: 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol:
将干燥的分子量为800Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.03:5,每100毫升无水甲苯中溶解5g的端甲氧基聚乙二醇; Dissolve dry methoxy-terminated polyethylene glycol with a molecular weight of 800Da, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate in anhydrous toluene, and react at 85°C under a nitrogen atmosphere for 48 hours , adding anhydrous n-hexane to the obtained reaction system for precipitation to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, di The molar ratio of dibutyltin laurate to 2,2'-dithiodiethylisocyanate is 1:0.03:5, and 5g of methoxy-terminated polyethylene glycol is dissolved in 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃反应36小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为9:1,每100毫升无水氯仿中溶解2g除水后的tPBLG-b-PDMAPMA,共沸除水时的回流温度为110℃,除水时间为6小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA was removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal was dissolved in anhydrous chloroform, and then Add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 60°C for 36 hours. After the reaction, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water for 48 Hours, three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization; Among them, 2,2'-dithiodiethylisocyanate-modified end-methyl polyethylene glycol and three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N- The molar ratio of (3-dimethylaminopropyl) methacrylamide) is 9: 1, and the tPBLG-b-PDMAPMA after dissolving 2g dehydration in every 100 milliliters of anhydrous chloroforms, the reflux temperature when azeotropic dehydration is 110℃, water removal time is 6 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水二甲基甲酰胺中,滴加无水肼后于40℃反应24小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为5:1;每100毫升无水二甲基甲酰胺中溶解10g三臂星形聚(L-谷 氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In dimethylformamide, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the reaction, the obtained reaction system is dialyzed in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dried to obtain a three-armed star Hydrophilic copolymer; Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-poly The molar ratio of benzyl protecting group in the ethylene glycol copolymer is 5:1; Dissolve 10g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer.
本实施例合成的三臂星形亲水性共聚物的化学名称为三臂星形聚(L-谷氨酸-γ-酰肼)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇亲水性共聚物,其结构式为 The chemical name of the three-arm star-shaped hydrophilic copolymer synthesized in this example is three-arm star poly(L-glutamic acid-γ-hydrazide)-poly(N-(3-dimethylaminopropyl) methyl Acrylamide)-polyethylene glycol hydrophilic copolymer, its structural formula is
1H-NMR谱图见图2。从图2可以看出,各个共聚物组分质子的化学位移均得到了很好的鉴定,表明该共聚物的合成是成功的。 See Figure 2 for the 1 H-NMR spectrum. It can be seen from Figure 2 that the chemical shifts of the protons of each copolymer component were well identified, indicating that the synthesis of the copolymer was successful.
本实施例合成的三臂星形亲水性共聚物载体装载阿霉素后,呈现两亲性性质,在水中可自组装成为纳米粒,动态光散射法测得的粒径分布图见图3。由图3可以看出,粒径分布范围为50纳米~110纳米,粒径分布范围窄,比较理想。 The three-armed star-shaped hydrophilic copolymer carrier synthesized in this example exhibits amphiphilic properties after being loaded with doxorubicin, and can self-assemble into nanoparticles in water. The particle size distribution diagram measured by dynamic light scattering method is shown in Figure 3 . It can be seen from Figure 3 that the particle size distribution range is 50 nm to 110 nm, and the particle size distribution range is narrow, which is ideal.
本实施例合成的三臂星形亲水性共聚物共装载阿霉素和绿色荧光剂FAM标记的siRNA后形成的纳米粒可经胞吞作用有效进入细胞内,其在细胞内的分布见图4。图4a中的B为DAPI染色的细胞核发出的荧光,图4b中的R为细胞核处的阿霉素发出的荧光,图4c中的G为FAM标记的bcl-2siRNA进入乳腺癌细胞MCF-7后的发出的荧光,将图4a-4c组合后,得到图4d,由图4d可以看出,阿霉素和bcl-2siRNA均可有效进入乳腺癌细胞MCF-7内,分布于细胞核周围,可见合成的载体可用于阿霉素和bcl-2siRNA的共同装载和递送。 The three-armed star-shaped hydrophilic copolymer synthesized in this example is co-loaded with doxorubicin and green fluorescent agent FAM-labeled siRNA to form nanoparticles that can effectively enter the cell through endocytosis, and its distribution in the cell is shown in the figure 4. B in Figure 4a is the fluorescence emitted by DAPI-stained nuclei, R in Figure 4b is the fluorescence emitted by doxorubicin at the nucleus, and G in Figure 4c is after FAM-labeled bcl-2siRNA enters breast cancer cell MCF-7 Figure 4d was obtained after combining Figures 4a-4c. It can be seen from Figure 4d that both doxorubicin and bcl-2 siRNA can effectively enter the breast cancer cell MCF-7 and distribute around the nucleus. It can be seen that the synthesis The vector can be used for co-loading and delivery of doxorubicin and bcl-2 siRNA.
实施例2: Example 2:
1)与实施例1中的步骤1)相同。 1) Same as step 1) in Example 1.
2)三臂聚(L-谷氨酸-γ-苄酯)(tPBLG)的合成: 2) Synthesis of three-arm poly(L-glutamate-γ-benzyl ester) (tPBLG):
将三(2-氨基乙基)胺经氢化钙回流12小时、氮气气氛下减压蒸馏得到无水三(2-氨基乙基)胺,然后将无水三(2-氨基乙基)胺溶于无水氯仿中,在氮气气氛下加入BLG-NCA,搅拌形成均匀溶液,于40℃反应60小时;反应结束后将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到白色粉末状tPBLG;其中,无水的三(2-氨基乙基)胺和BLG-NCA的摩尔比为1:60,每100毫升无水氯仿中溶解5g的BLG-NCA; Reflux tris(2-aminoethyl)amine through calcium hydride for 12 hours, and distill under reduced pressure under nitrogen atmosphere to obtain anhydrous tris(2-aminoethyl)amine, then dissolve anhydrous tris(2-aminoethyl)amine In anhydrous chloroform, add BLG-NCA under a nitrogen atmosphere, stir to form a uniform solution, and react at 40°C for 60 hours; after the reaction, the obtained reaction solution is precipitated with cold ether and washed with ethanol, and vacuum-dried to obtain a white powder tPBLG; wherein, the molar ratio of anhydrous tris(2-aminoethyl)amine and BLG-NCA is 1:60, and 5g of BLG-NCA is dissolved in every 100 milliliters of anhydrous chloroform;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水二甲基甲酰胺中,接着在氮气气氛下于0℃加入S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯(DDACT)、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),再在室温反应48小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA。其中,除水后的tPBLG、DDACT、DMAP以及DCC的摩尔比为1:12:3:30,每100毫升无水二甲基甲酰胺中溶解6g除水后的tPBLG;共沸除水时回流温度为120℃,除水时间2小时; The tPBLG was azeotropically dewatered with toluene under nitrogen to obtain tPBLG after dehydration. The tPBLG after dehydration was dissolved in anhydrous dimethylformamide, and then S-1-deca was added at 0°C under nitrogen atmosphere. Dialkyl-S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate (DDACT), 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC ), then precipitated with cold ether after reacting at room temperature for 48 hours, collected the precipitate and vacuum-dried to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, i.e. tPBLG-CTA Among them, the molar ratio of tPBLG, DDACT, DMAP and DCC after water removal is 1:12:3:30, and 6g of tPBLG after water removal is dissolved in every 100 ml of anhydrous dimethylformamide; The reflux temperature is 120°C, and the water removal time is 2 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入4,4'-偶氮双(氰基戊酸),于60℃反应48小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和4,4'-偶氮双(氰基戊酸)的摩尔比为1:290:14.4:0.36,每100毫升无水二氧六环中溶解10g的tPBLG-CTA; Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add 4, 4'-Azobis(cyanovaleric acid) was reacted at 60°C for 48 hours. After the reaction, the resulting reaction system was concentrated under reduced pressure to remove the solvent, dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and Dry in vacuo to obtain three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide), i.e. tPBLG-b-PDMAPMA; wherein, The molar ratio of tPBLG-CTA, DMAPMA, N-methylolacrylamide and 4,4'-azobis(cyanovaleric acid) is 1:290:14.4:0.36, per 100 ml of anhydrous dioxane Dissolve 10g of tPBLG-CTA;
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成:将干燥的分子量为4000Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.02:6,每100毫升无水甲苯中溶解10g的端甲氧基聚乙二醇; 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol: dry methoxy-terminated polyethylene glycol with a molecular weight of 4000Da, dibutyltin dilaurate and 2 , 2'-dithiodiethylisocyanate was dissolved in anhydrous toluene, and reacted for 48 hours at 85°C under a nitrogen atmosphere, and anhydrous n-hexane was added to the obtained reaction system to precipitate to obtain 2,2'-disulfide Methyl-terminated polyethylene glycol modified with substituted diethylisocyanate; wherein, the molar ratio of methyl-terminated polyethylene glycol, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate is 1: 0.02:6, dissolve 10g of methoxy-terminated polyethylene glycol in every 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃反应72小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为12:1;每100毫升无水氯仿中溶解2g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为115℃,除水时间为4小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA was removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal was dissolved in anhydrous chloroform, and then Add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 60°C for 72 hours. After the reaction, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water for 48 Hours, three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization; Among them, 2,2'-dithiodiethylisocyanate-modified end-methyl polyethylene glycol and three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N- The molar ratio of (3-dimethylaminopropyl) methacrylamide) is 12:1; Dissolve 2g of tPBLG-b-PDMAPMA after removing water in every 100 milliliters of anhydrous chloroform; The reflux temperature during azeotropic water removal is 115℃, water removal time is 4 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水二甲基甲酰胺中,滴加无水肼后于40℃反应24小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为8:1,每100毫升无水二甲基甲酰胺中溶解30g三臂星形聚(L-谷 氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In dimethylformamide, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the reaction, the obtained reaction system is dialyzed in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dried to obtain a three-armed star Hydrophilic copolymer; Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-poly The molar ratio of the benzyl protecting group in the ethylene glycol copolymer is 8:1, dissolve 30g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例3: Example 3:
1)与实施例1中的步骤1)相同。 1) Same as step 1) in Example 1.
2)三臂聚(L-谷氨酸-γ-苄酯)(tPBLG)的合成: 2) Synthesis of three-arm poly(L-glutamate-γ-benzyl ester) (tPBLG):
将三(2-氨基乙基)胺经氢化钙回流12小时、氮气气氛下减压蒸馏得到无水三(2-氨基乙基)胺,然后将无水三(2-氨基乙基)胺溶于无水四氢呋喃中,在氮气气氛下加入BLG-NCA,搅拌形成均匀溶液,于40℃反应48小时;反应结束后将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到白色粉末状tPBLG;其中,无水的三(2-氨基乙基)胺和BLG-NCA的摩尔比为1:45,每100毫升无水四氢呋喃中溶解5g的BLG-NCA; Reflux tris(2-aminoethyl)amine through calcium hydride for 12 hours, and distill under reduced pressure under nitrogen atmosphere to obtain anhydrous tris(2-aminoethyl)amine, then dissolve anhydrous tris(2-aminoethyl)amine In anhydrous tetrahydrofuran, add BLG-NCA under a nitrogen atmosphere, stir to form a uniform solution, and react at 40°C for 48 hours; after the reaction, the obtained reaction solution is precipitated with cold ether and washed with ethanol, and vacuum-dried to obtain a white powder tPBLG; wherein, the molar ratio of anhydrous tris(2-aminoethyl)amine and BLG-NCA is 1:45, and 5g of BLG-NCA is dissolved in every 100 milliliters of anhydrous tetrahydrofuran;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水氯仿中;接着在氮气气氛下于0℃加入S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯(DDACT)、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),随后再在室温反应48小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂;其中,除水后的tPBLG、DDACT、DMAP以及DCC的摩尔比为1:20:3:60,每100毫升无水氯仿中溶解3g除水后的tPBLG;共沸除水时回流温度为110℃,除水时间6小时; The tPBLG was azeotropically dewatered with toluene under nitrogen to obtain tPBLG after dehydration, and the tPBLG after dehydration was dissolved in anhydrous chloroform; then S-1-dodecyl- S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate (DDACT), 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC), followed by After reacting at room temperature for 48 hours, precipitate with cold ether, collect the precipitate and dry it in vacuo to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent; wherein, tPBLG after removing water The molar ratio of DDACT, DMAP and DCC is 1:20:3:60, and 3g of tPBLG after water removal is dissolved in 100 ml of anhydrous chloroform; the reflux temperature is 110°C during azeotropic water removal, and the water removal time is 6 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,利用氮气除氧后加入偶氮二异丁腈,于60℃反应48小时,反应结束后减压去除溶剂,用二氯甲烷溶解浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即 tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和4,4'-偶氮双(氰基戊酸)的摩尔比为1:144:7.2:0.64,每100毫升无水二氧六环中溶解4g的tPBLG-CTA; Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and add azobis Isobutyronitrile, reacted at 60°C for 48 hours, removed the solvent under reduced pressure after the reaction, dissolved and concentrated the reaction system obtained in dichloromethane to remove the solvent, dissolved in dichloromethane and precipitated in cold ether, collected the precipitate and vacuumed Dry to obtain three-arm star poly(L-glutamate-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl) methacrylamide), namely tPBLG-b-PDMAPMA; wherein, tPBLG - The molar ratio of CTA, DMAPMA, N-methylolacrylamide and 4,4'-azobis(cyanovaleric acid) is 1:144:7.2:0.64, dissolved in 100 ml of anhydrous dioxane 4g of tPBLG-CTA;
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成:将干燥的分子量为2000Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.04:6,每100毫升无水甲苯中溶解5g的端甲氧基聚乙二醇; 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol: dry methoxy-terminated polyethylene glycol with a molecular weight of 2000Da, dibutyltin dilaurate and 2 , 2'-dithiodiethylisocyanate was dissolved in anhydrous toluene, and reacted for 48 hours at 85°C under a nitrogen atmosphere, and anhydrous n-hexane was added to the obtained reaction system to precipitate to obtain 2,2'-disulfide Methyl-terminated polyethylene glycol modified with substituted diethylisocyanate; wherein, the molar ratio of methoxy-terminated polyethylene glycol, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate is 1 : 0.04:6, dissolve 5g of methoxy-terminated polyethylene glycol in every 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在无水氯仿溶解中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃反应48小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为24:1;每100毫升无水氯仿中溶解5g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为110℃,除水时间为6小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA was removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal was dissolved in anhydrous chloroform, Then add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 60°C for 48 hours. After the reaction is completed, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water After 48 hours, three-armed star-shaped poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization ; Among them, 2,2'-dithiodiethylisocyanate-modified terminal methyl polyethylene glycol and three-armed star poly(L-glutamic acid-γ-benzyl ester)-poly(N -(3-Dimethylaminopropyl) methacrylamide) in a molar ratio of 24:1; 5g of tPBLG-b-PDMAPMA dissolved in 100 ml of anhydrous chloroform; reflux temperature during azeotropic water removal The temperature is 110°C, and the water removal time is 6 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水二甲基甲酰胺中,滴加无水肼后于40℃反应24小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天, 最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为10:1,每100毫升无水二甲基甲酰胺中溶解25g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In dimethylformamide, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the reaction, the obtained reaction system is dialyzed in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dried to obtain a three-armed star Hydrophilic copolymer; Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-poly The molar ratio of benzyl protecting group in the ethylene glycol copolymer is 10:1, dissolves 25g three-arm star poly(L-glutamate-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例4: Example 4:
1)与实施例1中的步骤1)相同。 1) Same as step 1) in Example 1.
2)三臂星形聚(L-谷氨酸-γ-苄酯)(tPBLG)的合成: 2) Synthesis of three-arm star poly(L-glutamate-γ-benzyl ester) (tPBLG):
将三(2-氨基乙基)胺经氢化钙回流12小时、氮气气氛下减压蒸馏得到无水三(2-氨基乙基)胺,然后将无水三(2-氨基乙基)胺溶于无水二甲基甲酰胺中,在氮气气氛下加入BLG-NCA,搅拌形成均匀溶液,于30℃反应60小时;反应结束后将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到白色粉末状tPBLG;其中,三(2-氨基乙基)胺和BLG-NCA的摩尔比为1:120,每100毫升无水二甲基甲酰胺中溶解5g无水三(2-氨基乙基)胺; Reflux tris(2-aminoethyl)amine through calcium hydride for 12 hours, and distill under reduced pressure under nitrogen atmosphere to obtain anhydrous tris(2-aminoethyl)amine, then dissolve anhydrous tris(2-aminoethyl)amine In anhydrous dimethylformamide, add BLG-NCA under a nitrogen atmosphere, stir to form a uniform solution, and react at 30°C for 60 hours; after the reaction, the obtained reaction solution is precipitated with cold ether and washed with ethanol, and vacuum-dried Obtain white powdery tPBLG; wherein, the molar ratio of tris(2-aminoethyl)amine and BLG-NCA is 1:120, dissolve 5g of anhydrous tris(2-aminoethyl) in every 100 milliliters of anhydrous dimethylformamide base) amine;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水二甲基甲酰胺中,接着在氮气气氛下于0℃S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯(DDACT)、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),再在室温反应48小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、DDACT、DMAP以及DCC的摩尔比为1:20:3:60,每100毫升无水二甲基甲酰胺中溶解5.5g除水后的tPBLG;共沸除水时回流温度为110℃,除水时间6小时; tPBLG is dehydrated by azeotropic toluene under nitrogen to obtain tPBLG after dehydration, and the tPBLG after dehydration is dissolved in anhydrous dimethylformamide, followed by S-1-Dodeca at 0°C under nitrogen atmosphere. Alkyl-S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate (DDACT), 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC) , then reacted at room temperature for 48 hours and then precipitated with cold ether, collected the precipitate and dried in vacuo to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, i.e. tPBLG-CTA; Among them, the molar ratio of tPBLG, DDACT, DMAP and DCC after water removal is 1:20:3:60, and 5.5g of tPBLG after water removal is dissolved in every 100 ml of anhydrous dimethylformamide; The reflux temperature is 110°C, and the water removal time is 6 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入偶氮二异丁腈, 于60℃反应48小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和偶氮二异丁腈的摩尔比为1:216:10.8:1.44,每100毫升无水二氧六环中溶解7.5g的tPBLG-CTA; Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add azo Diisobutyronitrile was reacted at 60°C for 48 hours. After the reaction, the resulting reaction system was concentrated under reduced pressure to remove the solvent, dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and dried in vacuo to obtain a three-armed star Poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide), namely tPBLG-b-PDMAPMA; among them, tPBLG-CTA, DMAPMA, N- The molar ratio of methylolacrylamide and azobisisobutyronitrile is 1:216:10.8:1.44, and 7.5g of tPBLG-CTA is dissolved in every 100ml of anhydrous dioxane;
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成: 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol:
将干燥的分子量为2000Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.02:8,每100毫升无水甲苯中溶解5g的端甲氧基聚乙二醇; Dissolve dry methoxy-terminated polyethylene glycol with a molecular weight of 2000Da, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate in anhydrous toluene, and react at 85°C under a nitrogen atmosphere for 48 hours , adding anhydrous n-hexane to the obtained reaction system for precipitation to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, di The molar ratio of dibutyltin laurate to 2,2'-dithiodiethylisocyanate is 1:0.02:8, and 5g of methoxy-terminated polyethylene glycol is dissolved in 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃反应60小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为12:1;每100毫升无水氯仿中溶解5g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为120℃,除水时间为3小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA was removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal was dissolved in anhydrous chloroform, and then Add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol, and react at 60°C for 60 hours. After the reaction, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water for 48 Hours, three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization; Among them, 2,2'-dithiodiethylisocyanate-modified end-methyl polyethylene glycol and three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N- The molar ratio of (3-dimethylaminopropyl) methacrylamide) is 12:1; Dissolve 5g tPBLG-b-PDMAPMA after removing water in every 100 milliliters of anhydrous chloroforms; The reflux temperature during azeotropic water removal is 120℃, water removal time is 3 hours;
7)三臂星形三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰 胺)-聚乙二醇共聚物溶于无水四氢呋喃中,滴加无水肼后于40℃反应24小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为5:1;每100毫升无水四氢呋喃中溶解15g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous Add anhydrous hydrazine dropwise to tetrahydrofuran and react at 40°C for 24 hours. After the reaction, the obtained reaction system is dialyzed in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dried to obtain a three-armed star-shaped hydrophilic copolymer Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymerization The molar ratio of benzyl protecting group in the product is 5:1; Dissolve 15g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethyl aminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例5: Example 5:
1)与实施例1中的步骤1)相同。 1) Same as step 1) in Example 1.
2)三臂聚(L-谷氨酸-γ-苄酯)(tPBLG)的合成: 2) Synthesis of three-arm poly(L-glutamate-γ-benzyl ester) (tPBLG):
将三(2-氨基乙基)胺经氢化钙回流12小时、氮气气氛下减压蒸馏得到无水三(2-氨基乙基)胺,然后将无水三(2-氨基乙基)胺溶于无水四氢呋喃中,在氮气气氛下加入BLG-NCA,搅拌形成均匀溶液,于40℃反应60小时;反应结束后将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到白色粉末状tPBLG;其中,无水的三(2-氨基乙基)胺和BLG-NCA的摩尔比为1:80,每100毫升无水四氢呋喃中溶解8g的BLG-NCA; Reflux tris(2-aminoethyl)amine through calcium hydride for 12 hours, and distill under reduced pressure under nitrogen atmosphere to obtain anhydrous tris(2-aminoethyl)amine, then dissolve anhydrous tris(2-aminoethyl)amine In anhydrous tetrahydrofuran, add BLG-NCA under a nitrogen atmosphere, stir to form a uniform solution, and react at 40°C for 60 hours; after the reaction, the obtained reaction solution is precipitated with cold ether and washed with ethanol, and dried in vacuum to obtain a white powder tPBLG; wherein, the molar ratio of anhydrous tris(2-aminoethyl)amine and BLG-NCA is 1:80, and 8g of BLG-NCA is dissolved in every 100 milliliters of anhydrous tetrahydrofuran;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水氯仿中,接着在氮气气氛下于0℃加入S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯(DDACT)、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),随后再在室温反应48小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、DDACT、DMAP以及DCC的摩尔比为1:6:3:8,每100毫升无水氯仿中溶解5g除水后的tPBLG;共沸除水时回流温度为115℃,除水时间4小时; The tPBLG was dewatered by azeotropic toluene under nitrogen to obtain tPBLG after dehydration. The tPBLG after dehydration was dissolved in anhydrous chloroform, and then S-1-dodecyl- S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate (DDACT), 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC), followed by After reacting at room temperature for 48 hours, it was precipitated with cold ether, and the precipitate was collected and dried in vacuo to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, i.e. tPBLG-CTA; wherein, The molar ratio of tPBLG, DDACT, DMAP and DCC after water removal is 1:6:3:8, and 5g of tPBLG after water removal is dissolved in every 100 ml of anhydrous chloroform; Water time 4 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入偶氮二异丁腈,于60℃反应48小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即得到tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和偶氮二异丁腈的摩尔比为1:72:7.2:0.36,每100毫升无水二氧六环中溶解2g的tPBLG-CTA; Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add azo Diisobutyronitrile was reacted at 60°C for 48 hours. After the reaction, the resulting reaction system was concentrated under reduced pressure to remove the solvent, dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and vacuum-dried to obtain a three-armed star Poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide), that is, to obtain tPBLG-b-PDMAPMA; wherein, tPBLG-CTA, DMAPMA, N - The molar ratio of methylolacrylamide and azobisisobutyronitrile is 1:72:7.2:0.36, and 2g of tPBLG-CTA is dissolved in every 100 ml of anhydrous dioxane;
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成: 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol:
将干燥的分子量为800Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.05:4;每100毫升无水甲苯中溶解12g的端甲氧基聚乙二醇; Dissolve dry methoxy-terminated polyethylene glycol with a molecular weight of 800Da, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate in anhydrous toluene, and react at 85°C under a nitrogen atmosphere for 48 hours , adding anhydrous n-hexane to the obtained reaction system for precipitation to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, di The molar ratio of dibutyltin laurate to 2,2'-dithiodiethylisocyanate is 1:0.05:4; dissolve 12g of methoxy-terminated polyethylene glycol per 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在利用无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃反应52小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为25:1;每100毫升无水氯仿中溶解2g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为115℃,除水时间 为5小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA is removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal is dissolved in anhydrous chloroform, Then add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 60°C for 52 hours. After the reaction is completed, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water After 48 hours, three-armed star-shaped poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization ; Among them, 2,2'-dithiodiethylisocyanate-modified terminal methyl polyethylene glycol and three-armed star poly(L-glutamic acid-γ-benzyl ester)-poly(N -(3-dimethylaminopropyl) methacrylamide) in a molar ratio of 25:1; 2 g of tPBLG-b-PDMAPMA dissolved in 100 ml of anhydrous chloroform; reflux temperature during azeotropic water removal The temperature is 115°C, and the water removal time is 5 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水氯仿中,滴加无水肼后于40℃反应24小时,应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为20:1;每100毫升无水氯仿中溶解8g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In chloroform, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the completion of the reaction, dialyze the obtained reaction system in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dry to obtain a three-armed star-shaped hydrophilic copolymer Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymerization The molar ratio of benzyl protecting group in the compound is 20:1; Dissolve 8g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethyl aminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例6: Embodiment 6:
1)与实施例1中的步骤1)相同。 1) Same as step 1) in Example 1.
2)三臂星形聚(L-谷氨酸-γ-苄酯)(tPBLG)的合成: 2) Synthesis of three-arm star poly(L-glutamate-γ-benzyl ester) (tPBLG):
将三(2-氨基乙基)胺经氢化钙回流12小时、氮气气氛下减压蒸馏得到无水三(2-氨基乙基)胺,然后将无水三(2-氨基乙基)胺溶于无水氯仿中,在氮气气氛下加入BLG-NCA,搅拌形成均匀溶液,然后于25℃反应70小时;将得到的反应液用冷乙醚沉淀和乙醇洗涤,真空干燥后得到白色粉末状的三臂聚(L-谷氨酸-γ-苄酯)(tPBLG);其中,无水的三(2-氨基乙基)胺和BLG-NCA的摩尔比为1:90,每100毫升无水氯仿中溶解10g无水三(2-氨基乙基)胺; Reflux tris(2-aminoethyl)amine through calcium hydride for 12 hours, and distill under reduced pressure under nitrogen atmosphere to obtain anhydrous tris(2-aminoethyl)amine, then dissolve anhydrous tris(2-aminoethyl)amine In anhydrous chloroform, add BLG-NCA under a nitrogen atmosphere, stir to form a uniform solution, and then react at 25 ° C for 70 hours; the obtained reaction solution is precipitated with cold ether and washed with ethanol, and vacuum-dried to obtain a white powder. arm poly(L-glutamic acid-γ-benzyl ester) (tPBLG); wherein, the molar ratio of anhydrous tris(2-aminoethyl)amine and BLG-NCA is 1:90, and every 100 ml of anhydrous chloroform Dissolve 10g of anhydrous tris(2-aminoethyl)amine in
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水二甲基甲酰胺中,接着在氮气气氛下于0℃加入S-1-十二烷基-S'-(α,α'-二甲基-α″-乙酸)三硫代碳酸酯(DDACT)、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),再在室温反应48小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、DDACT、DMAP以及DCC的摩尔比为1:18:3:40,每100毫升无水二甲基甲酰胺中溶解6g除水后的 tPBLG;共沸除水时回流温度为110℃,除水时间6小时; The tPBLG was azeotropically dewatered with toluene under nitrogen to obtain tPBLG after dehydration. The tPBLG after dehydration was dissolved in anhydrous dimethylformamide, and then S-1-deca was added at 0°C under nitrogen atmosphere. Dialkyl-S'-(α,α'-dimethyl-α″-acetic acid) trithiocarbonate (DDACT), 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC ), then precipitated with cold ether after reacting at room temperature for 48 hours, collected the precipitate and vacuum-dried to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, i.e. tPBLG-CTA Wherein, the molar ratio of tPBLG, DDACT, DMAP and DCC after water removal is 1:18:3:40, and 6g of tPBLG after water removal is dissolved in every 100 milliliters of anhydrous dimethylformamide; The reflux temperature is 110°C, and the water removal time is 6 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入4,4'-偶氮双(氰基戊酸),于60℃反应48小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即得到tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和4,4'-偶氮双(氰基戊酸)的摩尔比为1:290:14.4:1.08,每100毫升无水二氧六环中溶解8.5g的tPBLG-CTA。 Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add 4, 4'-Azobis(cyanovaleric acid) was reacted at 60°C for 48 hours. After the reaction, the resulting reaction system was concentrated under reduced pressure to remove the solvent, dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and Vacuum drying to obtain three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide), namely to obtain tPBLG-b-PDMAPMA; wherein , the molar ratio of tPBLG-CTA, DMAPMA, N-methylolacrylamide, and 4,4'-azobis(cyanovaleric acid) was 1:290:14.4:1.08 per 100 mL of anhydrous dioxane Dissolve 8.5 g of tPBLG-CTA in the medium.
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成: 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol:
将干燥的分子量为800Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.07:8,每100毫升无水甲苯中溶解16g的端甲氧基聚乙二醇; Dissolve dry methoxy-terminated polyethylene glycol with a molecular weight of 800Da, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate in anhydrous toluene, and react at 85°C under a nitrogen atmosphere for 48 hours , adding anhydrous n-hexane to the obtained reaction system for precipitation to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, di The molar ratio of dibutyltin laurate to 2,2'-dithiodiethylisocyanate is 1:0.07:8, and 16g of methoxy-terminated polyethylene glycol is dissolved in 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于60℃反应45小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯 改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为30:1,每100毫升无水氯仿中溶解3.5g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为120℃,除水时间为2小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA was removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal was dissolved in anhydrous chloroform, and then Add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 60°C for 45 hours. After the reaction, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water for 48 Hours, three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization; Among them, 2,2'-dithiodiethylisocyanate-modified end-methyl polyethylene glycol and three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N- (3-Dimethylaminopropyl) methacrylamide) at a molar ratio of 30:1, dissolve 3.5g of tPBLG-b-PDMAPMA after dehydration in every 100 milliliters of anhydrous chloroform; reflux temperature during azeotropic dehydration The temperature is 120°C, and the water removal time is 2 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水二甲基甲酰胺中,滴加无水肼后于40℃反应24小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为3:1;每100毫升无水二甲基甲酰胺中溶解12g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In dimethylformamide, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the reaction, the obtained reaction system is dialyzed in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dried to obtain a three-armed star Hydrophilic copolymer; Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-poly The molar ratio of benzyl protecting group in the ethylene glycol copolymer is 3:1; Dissolve 12g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例7: Embodiment 7:
1)γ-苄酯-L-谷氨酸-N-羧基环内酸酐(BLG-NCA)合成: 1) Synthesis of γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride (BLG-NCA):
将L-谷氨酸-γ-苄酯加入无水四氢呋喃中,接着在氮气氛下加入三光气,随后于50℃反应至形成澄清溶液后减压浓缩以除去大部分溶剂,最后向浓缩后得到的反应体系中加入无水正己烷使沉淀,将得到的沉淀用无水正己烷重结晶,得到γ-苄酯-L-谷氨酸-N-羧基环内酸酐(BLG-NCA);其中,L-谷氨酸-γ-苄酯与三光气的摩尔比为1:0.38,每100毫升无水四氢呋喃中溶解15g的L-谷氨酸-γ-苄酯; Add L-glutamic acid-γ-benzyl ester into anhydrous tetrahydrofuran, then add triphosgene under nitrogen atmosphere, then react at 50°C until a clear solution is formed, then concentrate under reduced pressure to remove most of the solvent, and finally concentrate to obtain Anhydrous n-hexane is added in the reaction system to precipitate, and the precipitate obtained is recrystallized with anhydrous n-hexane to obtain γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride (BLG-NCA); wherein, The molar ratio of L-glutamic acid-γ-benzyl ester to triphosgene is 1:0.38, and 15g of L-glutamic acid-γ-benzyl ester is dissolved in every 100 ml of anhydrous tetrahydrofuran;
2)与实施例6步骤2)相同; 2) Same as embodiment 6 step 2);
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水二甲基甲酰胺中,接着在氮气气氛下于0℃加入4-氰基-4-[(十二烷基硫烷基硫羰基)硫烷基]戊酸、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),再在室温反应24小时后用冷乙醚沉淀,收集沉淀并真空干 燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、4-氰基-4-[(十二烷基硫烷基硫羰基)硫烷基]戊酸、DMAP以及DCC的摩尔比为1:6:3:6,每100毫升无水二甲基甲酰胺中溶解4g除水后的tPBLG;共沸除水时回流温度为110℃,除水时间6小时; The tPBLG was azeotropically dewatered with toluene under nitrogen to obtain tPBLG after dehydration. The tPBLG after dehydration was dissolved in anhydrous dimethylformamide, and then 4-cyano- 4-[(dodecylsulfanylthiocarbonyl)sulfanyl]valeric acid, 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC), and then reacted at room temperature for 24 hours with Precipitate with cold ether, collect the precipitate and vacuum-dry to obtain a yellow solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, i.e. tPBLG-CTA; wherein, tPBLG after water removal, 4 -Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid, DMAP and DCC in a molar ratio of 1:6:3:6 per 100 ml of anhydrous dimethylformamide Dissolve 4g of tPBLG after dehydration in the medium; the reflux temperature during azeotropic dehydration is 110°C, and the dehydration time is 6 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入4,4'-偶氮双(氰基戊酸),于65℃反应36小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即得到tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和4,4'-偶氮双(氰基戊酸)的摩尔比为1:290:14.4:1.08,每100毫升无水二氧六环中溶解7g的tPBLG-CTA。 Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add 4, 4'-Azobis(cyanovaleric acid) was reacted at 65°C for 36 hours. After the reaction was completed, the reaction system was concentrated under reduced pressure to remove the solvent, and then dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and Vacuum drying to obtain three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide), namely to obtain tPBLG-b-PDMAPMA; wherein , the molar ratio of tPBLG-CTA, DMAPMA, N-methylolacrylamide, and 4,4'-azobis(cyanovaleric acid) was 1:290:14.4:1.08 per 100 mL of anhydrous dioxane Dissolve 7 g of tPBLG-CTA in the medium.
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成: 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol:
将干燥的分子量为3000Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.08:3,每100毫升无水甲苯中溶解24g的端甲氧基聚乙二醇; Dissolve dry methoxy-terminated polyethylene glycol with a molecular weight of 3000Da, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate in anhydrous toluene, and react at 85°C under a nitrogen atmosphere for 48 hours , adding anhydrous n-hexane to the obtained reaction system for precipitation to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, di The molar ratio of dibutyltin laurate to 2,2'-dithiodiethylisocyanate is 1:0.08:3, and 24g of methoxy-terminated polyethylene glycol is dissolved in 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物合成: 6) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在无 水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于64℃反应45小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析57小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为36:1,每100毫升无水氯仿中溶解4g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为120℃,除水时间为2小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA was removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal was dissolved in anhydrous chloroform, and then Add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 64°C for 45 hours. After the reaction, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water for 57 Hours, three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization; Among them, 2,2'-dithiodiethylisocyanate-modified end-methyl polyethylene glycol and three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N- The mol ratio of (3-dimethylaminopropyl) methacrylamide) is 36:1, dissolves 4g tPBLG-b-PDMAPMA after removing water in every 100 milliliters of anhydrous chloroforms; The reflux temperature during azeotropic water removal is 120℃, water removal time is 2 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水二甲基甲酰胺中,滴加无水肼后于40℃反应24小时,反应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为3:1;每100毫升无水二甲基甲酰胺中溶解16g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In dimethylformamide, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the reaction, the obtained reaction system is dialyzed in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dried to obtain a three-armed star Hydrophilic copolymer; Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-poly The molar ratio of benzyl protecting group in the ethylene glycol copolymer is 3:1; Dissolve 16g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例8: Embodiment 8:
1)γ-苄酯-L-谷氨酸-N-羧基环内酸酐(BLG-NCA)合成: 1) Synthesis of γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride (BLG-NCA):
将L-谷氨酸-γ-苄酯加入无水四氢呋喃中,接着在氮气氛下加入三光气,随后于50℃反应至形成澄清溶液后减压浓缩以除去大部分溶剂,最后向浓缩后得到的反应体系中加入无水正己烷使沉淀,将得到的沉淀用无水正己烷重结晶,得到γ-苄酯-L-谷氨酸-N-羧基环内酸酐(BLG-NCA);其中,L-谷氨酸-γ-苄酯与三光气的摩尔比为1:0.4,每100毫升无水四氢呋喃中溶解5g的L-谷氨酸-γ-苄酯; Add L-glutamic acid-γ-benzyl ester into anhydrous tetrahydrofuran, then add triphosgene under nitrogen atmosphere, then react at 50°C until a clear solution is formed, then concentrate under reduced pressure to remove most of the solvent, and finally concentrate to obtain Anhydrous n-hexane is added in the reaction system to precipitate, and the obtained precipitate is recrystallized with anhydrous n-hexane to obtain γ-benzyl ester-L-glutamic acid-N-carboxyl anhydride (BLG-NCA); wherein, The molar ratio of L-glutamic acid-γ-benzyl ester to triphosgene is 1:0.4, and 5g of L-glutamic acid-γ-benzyl ester is dissolved in every 100 ml of anhydrous tetrahydrofuran;
2)与实施例6的步骤2)相同; 2) same as step 2) of embodiment 6;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水氯仿中,接着在氮气气氛下于0℃加入4-氰基戊酸二硫代苯甲酸、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),随后再在室温反应72小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、4-氰基戊酸二硫代苯甲酸、DMAP以及DCC的摩尔比为1:6:3:8,每100毫升无水氯仿中溶解5g除水后的tPBLG;共沸除水时回流温度为115℃,除水时间4小时; The tPBLG was azeotropically dewatered by toluene under nitrogen to obtain tPBLG after dehydration. The tPBLG after dehydration was dissolved in anhydrous chloroform, and then 4-cyanopentanoic acid dithiocarbamate was added at 0°C under nitrogen atmosphere. Benzoic acid, 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC), followed by precipitation with cold ether after reacting at room temperature for 72 hours, collected the precipitate and dried in vacuo to obtain a yellow solid product three-arm poly (L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, namely tPBLG-CTA; wherein, the molar ratio of tPBLG, 4-cyanovaleric acid dithiobenzoic acid, DMAP and DCC after water removal 1:6:3:8, dissolve 5g of tPBLG after dehydration in every 100ml of anhydrous chloroform; the reflux temperature during azeotropic dehydration is 115℃, and the dehydration time is 4 hours;
4)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)(tPBLG-b-PDMAPMA)的合成: 4) Synthesis of three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide) (tPBLG-b-PDMAPMA):
将tPBLG-CTA、N-(3-二甲胺丙基)甲基丙烯酰胺(DMAPMA)、N-羟甲基丙烯酰胺溶于无水二氧六环中,然后利用氮气除氧后加入偶氮二异丁腈,于61℃反应72小时,反应结束后减压浓缩得到的反应体系以去除溶剂,再用二氯甲烷溶解后在冷乙醚中沉淀,收集沉淀并真空干燥,得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺),即得到tPBLG-b-PDMAPMA;其中,tPBLG-CTA、DMAPMA、N-羟甲基丙烯酰胺和偶氮二异丁腈的摩尔比为1:72:7.2:0.36,每100毫升无水二氧六环中溶解2g的tPBLG-CTA; Dissolve tPBLG-CTA, N-(3-dimethylaminopropyl)methacrylamide (DMAPMA), and N-methylolacrylamide in anhydrous dioxane, and then add azo Diisobutyronitrile was reacted at 61°C for 72 hours. After the reaction, the resulting reaction system was concentrated under reduced pressure to remove the solvent, dissolved in dichloromethane and precipitated in cold ether. The precipitate was collected and vacuum-dried to obtain a three-armed star Poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide), that is, to obtain tPBLG-b-PDMAPMA; wherein, tPBLG-CTA, DMAPMA, N - The molar ratio of methylolacrylamide and azobisisobutyronitrile is 1:72:7.2:0.36, and 2g of tPBLG-CTA is dissolved in every 100 ml of anhydrous dioxane;
5)2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇的合成: 5) Synthesis of 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol:
将干燥的分子量为800Da的端甲氧基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯溶于无水甲苯中,于85℃氮气氛下反应48小时,向得到的反应体系中加入无水正己烷使沉淀,得到2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇;其中,端甲基聚乙二醇、二月桂酸二丁基锡和2,2'-二硫代二乙基异氰酸酯的摩尔比为1:0.05:4;每100毫升无水甲苯中溶解30g的端甲氧基聚乙二醇; Dissolve dry methoxy-terminated polyethylene glycol with a molecular weight of 800Da, dibutyltin dilaurate and 2,2'-dithiodiethylisocyanate in anhydrous toluene, and react at 85°C under a nitrogen atmosphere for 48 hours , adding anhydrous n-hexane to the obtained reaction system for precipitation to obtain 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol; wherein, methyl-terminated polyethylene glycol, di The molar ratio of dibutyltin laurate to 2,2'-dithiodiethylisocyanate is 1:0.05:4; dissolve 30g of methoxy-terminated polyethylene glycol per 100ml of anhydrous toluene;
6)三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚 乙二醇共聚物合成: 6) three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymer synthesis:
在氮气气氛下利用甲苯共沸法除去tPBLG-b-PDMAPMA所含痕量水,得到除水后的tPBLG-b-PDMAPMA,将除水后的tPBLG-b-PDMAPMA溶解在利用无水氯仿中,然后加入2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇,于65℃反应52小时,反应结束后浓缩得到的反应体系,并用乙醚沉淀,接着在蒸馏水中透析48小时,冻干后得到三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物;其中,2,2'-二硫代二乙基异氰酸酯改性的端甲基聚乙二醇和除水后的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)的摩尔比为25:1;每100毫升无水氯仿中溶解2g除水后的tPBLG-b-PDMAPMA;共沸除水时的回流温度为115℃,除水时间为5小时; Under a nitrogen atmosphere, the trace water contained in tPBLG-b-PDMAPMA is removed by toluene azeotropic method to obtain tPBLG-b-PDMAPMA after water removal, and the tPBLG-b-PDMAPMA after water removal is dissolved in anhydrous chloroform, Then add 2,2'-dithiodiethylisocyanate-modified methyl-terminated polyethylene glycol and react at 65°C for 52 hours. After the reaction, the resulting reaction system is concentrated and precipitated with ether, followed by dialysis in distilled water After 48 hours, three-armed star-shaped poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer was obtained after lyophilization ; Among them, 2,2'-dithiodiethylisocyanate-modified terminal methyl polyethylene glycol and three-armed star poly(L-glutamic acid-γ-benzyl ester)-poly(N -(3-dimethylaminopropyl) methacrylamide) in a molar ratio of 25:1; 2 g of tPBLG-b-PDMAPMA dissolved in 100 ml of anhydrous chloroform; reflux temperature during azeotropic water removal The temperature is 115°C, and the water removal time is 5 hours;
7)三臂星形亲水性共聚物的合成: 7) Synthesis of three-arm star-shaped hydrophilic copolymer:
将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水氯仿中,滴加无水肼后于40℃反应24小时,应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为20:1;每100毫升无水氯仿中溶解22g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in anhydrous In chloroform, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the completion of the reaction, dialyze the obtained reaction system in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dry to obtain a three-armed star-shaped hydrophilic copolymer Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene glycol copolymerization The molar ratio of benzyl protecting group in the compound is 20:1; Dissolve 22g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethyl aminopropyl)methacrylamide)-polyethylene glycol copolymer.
实施例9: Embodiment 9:
1)与实施例6的步骤1)相同; 1) same as step 1) of embodiment 6;
2)与实施例6的步骤2)相同; 2) same as step 2) of embodiment 6;
3)三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂的合成: 3) Synthesis of three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent:
将tPBLG在氮气下经甲苯共沸除水,得到除水后的tPBLG,将除水后的tPBLG溶于无水氯仿中,接着在氮气气氛下于0℃加入4-氰基-4-(硫代苯甲酰)戊酸、4-二甲氨基吡啶(DMAP)和二环己基碳二亚胺(DCC),随后再在室 温反应72小时后用冷乙醚沉淀,收集沉淀并真空干燥,得到黄色固体产物三臂聚(L-谷氨酸-γ-苄酯)大分子RAFT链转移剂,即tPBLG-CTA;其中,除水后的tPBLG、4-氰基-4-(硫代苯甲酰)戊酸、DMAP以及DCC的摩尔比为1:6:3:8,每100毫升无水氯仿中溶解2.5g除水后的tPBLG;共沸除水时回流温度为115℃,除水时间4小时; tPBLG was dewatered by azeotropic toluene under nitrogen to obtain tPBLG after dehydration. The tPBLG after dehydration was dissolved in anhydrous chloroform, and then 4-cyano-4-(sulfur Benzoyl) valeric acid, 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC), followed by precipitation with cold ether after 72 hours at room temperature, the precipitate was collected and dried in vacuo to give a yellow The solid product three-arm poly(L-glutamic acid-γ-benzyl ester) macromolecular RAFT chain transfer agent, namely tPBLG-CTA; wherein, tPBLG after water removal, 4-cyano-4-(thiobenzoyl ) The molar ratio of valeric acid, DMAP and DCC is 1:6:3:8, and 2.5g of tPBLG after water removal is dissolved in every 100 ml of anhydrous chloroform; the reflux temperature is 115°C during azeotropic water removal, and the water removal time is 4 Hour;
4)与实施例6的步骤4)相同; 4) same as step 4) of embodiment 6;
5)与实施例6的步骤5)相同; 5) same as step 5) of embodiment 6;
6)与实施例6的步骤6)相同; 6) same as step 6) of embodiment 6;
7)将干燥的三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物溶于无水氯仿中,滴加无水肼后于40℃反应24小时,应结束后将得到的反应体系在质量浓度为0.25%的氨水中透析2天,最后冻干,得到三臂星形亲水性共聚物;其中,无水肼与三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物中苄基保护基的摩尔比为20:1;每100毫升无水氯仿中溶解5g三臂星形聚(L-谷氨酸-γ-苄酯)-聚(N-(3-二甲胺丙基)甲基丙烯酰胺)-聚乙二醇共聚物。 7) Dissolve the dry three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3-dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer in In anhydrous chloroform, add anhydrous hydrazine dropwise and react at 40°C for 24 hours. After the completion of the reaction, dialyze the obtained reaction system in ammonia water with a mass concentration of 0.25% for 2 days, and finally freeze-dry to obtain a three-armed star-shaped hydrophilic Sexual copolymer; Among them, anhydrous hydrazine and three-arm star poly (L-glutamic acid-γ-benzyl ester)-poly (N-(3-dimethylaminopropyl) methacrylamide)-polyethylene di The molar ratio of benzyl protecting group in the alcohol copolymer is 20:1; Dissolve 5g three-arm star poly(L-glutamic acid-γ-benzyl ester)-poly(N-(3- Dimethylaminopropyl)methacrylamide)-polyethylene glycol copolymer.
上述实施例1-9中的冷乙醚温度为零下-20℃,真空干燥温度在30℃,冻干温度为-40℃,反应体系浓缩时,浓缩到原来体积的三分之一到二分之一。 The cold ether temperature in the above-mentioned examples 1-9 is -20°C below zero, the vacuum drying temperature is 30°C, and the freeze-drying temperature is -40°C. When the reaction system is concentrated, it is concentrated to one-third to one-half of the original volume one.
本发明中2,2'-二硫代二乙基异氰酸酯改性的端甲氧基聚乙二醇即申请号为201310229284.7的中国专利实施例4步骤3)的产物2,2'-二硫代二乙基异氰酸酯改性聚乙二醇。 The methoxy-terminated polyethylene glycol modified by 2,2'-dithiodiethylisocyanate in the present invention is the product 2,2'-dithio Diethyl isocyanate modified polyethylene glycol.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410267395.1A CN104045837B (en) | 2014-06-16 | 2014-06-16 | A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410267395.1A CN104045837B (en) | 2014-06-16 | 2014-06-16 | A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104045837A CN104045837A (en) | 2014-09-17 |
CN104045837B true CN104045837B (en) | 2016-08-17 |
Family
ID=51499260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410267395.1A Expired - Fee Related CN104045837B (en) | 2014-06-16 | 2014-06-16 | A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104045837B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105669912B (en) * | 2016-03-03 | 2018-03-13 | 江苏中铁奥莱特新材料股份有限公司 | A kind of method for preparing star-like poly carboxylic acid series water reducer |
CN106750047B (en) * | 2016-11-28 | 2020-01-21 | 北京化工大学 | Preparation method of pH-responsive adriamycin nano-drug capsule with positive surface charge |
CN112279984B (en) * | 2020-10-30 | 2023-05-09 | 浙江理工大学 | Method for preparing catalytic nanospheres by polymerization-induced self-assembly |
CN118852545A (en) * | 2024-06-27 | 2024-10-29 | 锐康九域(厦门)医药科技有限公司 | A polymer carrier and a pharmaceutical composition and their application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102336913A (en) * | 2011-07-01 | 2012-02-01 | 山东理工大学 | Poly(N-isopropyl acrylamide)-polyurethane-polypeptide block-graft copolymer and preparation method thereof |
-
2014
- 2014-06-16 CN CN201410267395.1A patent/CN104045837B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102336913A (en) * | 2011-07-01 | 2012-02-01 | 山东理工大学 | Poly(N-isopropyl acrylamide)-polyurethane-polypeptide block-graft copolymer and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104045837A (en) | 2014-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Davaran et al. | Novel dual stimuli-responsive ABC triblock copolymer: RAFT synthesis,“schizophrenic” micellization, and its performance as an anticancer drug delivery nanosystem | |
Li et al. | Ternary polyplex micelles with PEG shells and intermediate barrier to complexed DNA cores for efficient systemic gene delivery | |
CN110023407B (en) | Labeled poly(esteramide urethane), nanoparticles formed therefrom and uses thereof | |
CN103665384B (en) | Novel cation graft copolymer and MULTIPLE COMPOSITE non-viral gene vector preparation method and application | |
CN108498483B (en) | A kind of preparation method of pH/reduction-responsive polyamino acid zwitterionic nanoparticles | |
KR20130006663A (en) | Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery | |
CN107298741B (en) | A block polymer, a drug carrier containing it, its preparation method and application | |
CN107596380B (en) | Reduction-sensitive camptothecin prodrugs based on polyethylene glycol-polycarbonate and their preparation methods and applications | |
CN104045837B (en) | A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application | |
CN102600063A (en) | Method for preparing curcumin micelle with high medicine loading | |
CN106317416A (en) | Double-pH-response amphiphilic copolymer and preparation method and application thereof | |
CN103251596A (en) | 7-ethyl-10-hydroxycamptothecin amphiphilic polymer prodrug as well as preparation method and nano-particles thereof | |
Lin et al. | Cationic micellar nanoparticles for DNA and doxorubicin co-delivery | |
Zeng et al. | A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient andbiocompatible gene delivery vector | |
CN104027813B (en) | A kind of pH/ reduces the hydrophilic copolymers pharmaceutical carrier of Dual Sensitive and synthetic method thereof and application | |
CN105963706A (en) | Branched polyHPMA copolymer-DOX conjugate, and preparation method and application thereof | |
CN104031270B (en) | Type polyethylene glycol (Pidolidone-γ-benzyl ester)-polyethylene imine copolymer and synthetic method thereof and application can be will be completely dissociated | |
CN104086721B (en) | Poly-(Pidolidone-γ-hydrazides)-PDMAPMA triblock copolymer of mPEG-and synthetic method thereof and application | |
CN107998082A (en) | A kind of application for reducing responsive polymer vesica Nano medication in treatment of brain tumor medicine is prepared | |
CN106890336B (en) | siRNA drug carrier polymer, preparation method thereof and application thereof in siRNA targeted delivery | |
JP6238263B2 (en) | Drug delivery polycarbonate having aromatic N-heterocycle | |
CN104311830B (en) | Dendritic gene and drug carrier, and preparation and application thereof | |
CN104027816B (en) | Co-loaded adriamycin and siRNA (small interfering ribose nucleic acid) carrier capable of removing pegylation and synthesis method thereof | |
CN103936945B (en) | Efficient anti-tumor targeting drug carrier and preparation method thereof | |
Jin et al. | Synthesis and application of spermine-based amphiphilic poly (β-amino ester) s for siRNA delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 Termination date: 20190616 |